1. Home
  2. NAKA vs UNCY Comparison

NAKA vs UNCY Comparison

Compare NAKA & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kindly MD Inc.

NAKA

Kindly MD Inc.

HOLD

Current Price

$9.97

Market Cap

152.1M

Sector

N/A

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$4.72

Market Cap

150.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAKA
UNCY
Founded
2019
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.1M
150.1M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
NAKA
UNCY
Price
$9.97
$4.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$0.75
★ $25.67
AVG Volume (30 Days)
207.4K
★ 718.0K
Earning Date
05-20-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.19
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $675,000.00
Revenue This Year
$1,514.38
N/A
Revenue Next Year
$48.27
$582.86
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$3.93
52 Week High
$10.27
$8.74

Technical Indicators

Market Signals
Indicator
NAKA
UNCY
Relative Strength Index (RSI) 70.27 39.06
Support Level $0.24 $3.93
Resistance Level N/A $5.86
Average True Range (ATR) 0.60 0.23
MACD 0.08 -0.02
Stochastic Oscillator 90.41 9.50

Price Performance

Historical Comparison
NAKA
UNCY

About NAKA Kindly MD Inc.

Nakamoto Inc is a Bitcoin company building a world-wide portfolio of Bitcoin-native companies to provide commercial and financial infrastructure for the next generation of capital markets. The firm has two principal business segments: Bitcoin Operations, which houses its Bitcoin treasury and is utilized to support investments in other Bitcoin-related companies; Healthcare Operations, which provides a patient-focused healthcare experience that provides patients personalized solutions in order to reduce opioid use and improve health outcomes. The company generates the majority of its revenue from the Healthcare Operations.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: